Frontiers in Molecular Neuroscience (Nov 2023)

Impaired synaptic incorporation of AMPA receptors in a mouse model of fragile X syndrome

  • Magdalena Chojnacka,
  • Anna Beroun,
  • Marta Magnowska,
  • Aleksandra Stawikowska,
  • Dominik Cysewski,
  • Jacek Milek,
  • Magdalena Dziembowska,
  • Bozena Kuzniewska

DOI
https://doi.org/10.3389/fnmol.2023.1258615
Journal volume & issue
Vol. 16

Abstract

Read online

Fragile X syndrome (FXS) is the most common monogenetic cause of inherited intellectual disability and autism in humans. One of the well-characterized molecular phenotypes of Fmr1 KO mice, a model of FXS, is increased translation of synaptic proteins. Although this upregulation stabilizes in adulthood, abnormalities during the critical period of plasticity have long-term effects on circuit formation and synaptic properties. Using high-resolution quantitative proteomics of synaptoneurosomes isolated from the adult, developed brains of Fmr1 KO mice, we show a differential abundance of proteins regulating the postsynaptic receptor activity of glutamatergic synapses. We investigated the AMPA receptor composition and shuttling in adult Fmr1 KO and WT mice using a variety of complementary experimental strategies such as surface protein crosslinking, immunostaining of surface receptors, and electrophysiology. We discovered that the activity-dependent synaptic delivery of AMPARs is impaired in adult Fmr1 KO mice. Furthermore, we show that Fmr1 KO synaptic AMPARs contain more GluA2 subunits that can be interpreted as a switch in the synaptic AMPAR subtype toward an increased number of Ca2+−impermeable receptors in adult Fmr1 KO synapses.

Keywords